source
- 5 takeaways from STAT’s investigation into microhospital operator Nutex HealthRead the takeaways from STAT's investigation into Nutex, which used the No Surprises Act to fuel a stunning financial turnaround.
- FDA’s top gene-therapy regulator Vijay Kumar steps down amid leadership shake-upVijay Kumar, the acting director of the FDA office that reviews cell and gene therapies, has announced he will leave his position. In an email to staff, Kumar said he reflected on his tenure and de…